NCT00437463View on ClinicalTrials.gov

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Glomerulonephritis
Interventions
DRUG

Ramipril

2.5mg and increase to 5mg if patient do not develop symptomatic hypotension

Trial Locations (1)

Unknown

Sanofi-Aventis, Hong Kong

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00437463 - Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor | Biotech Hunter | Biotech Hunter